Tadalafil ZPHC — 100 × 20 mg tablets

Tadalafil — long-acting PDE-5 inhibitor
100 film-coated tablets × 20 mg
Duration: extended half-life (~36 h) enables flexible timing (“weekend window”).
Profiles: on-demand 10–20 mg; or daily micro-dose 2.5–5 mg for steady plasma levels (research examples).
Selectivity: higher PDE-5/PDE-6 ratio → fewer visual side effects vs sildenafil.
Interactions: avoid nitrates/riociguat; caution with α-blockers & strong CYP3A4 inhibitors; monitor blood pressure.
QC: ≥ 99% API purity (HPLC); GMP tablet press; tamper-evident cap with scratch-code authenticity.
*For laboratory research use only. Not approved as a medicinal product.*, Tadalafil ZPHC — 100 × 20 mg tablets, 41, USD, ,